Hypertension and stroke

doi:10.1017/CBO9780511545672.013

13 - Hypertension and stroke

from Part III - Disease prevention

Published online by Cambridge University Press: 21 August 2009

Jo Ann Rosenfeld

Edited by

Jo Ann Rosenfeld

Show author details

Jo Ann Rosenfeld: Affiliation:
Johns Hopkins School of Medicine, Baltimore, MD
Jo Ann Rosenfeld: Affiliation:
The Johns Hopkins University

Book contents

Get access

Summary

Case: M.M. is a 54-year-old obese woman who has not seen a physician in two years. She has a history of hypertension and high cholesterol. She works full time as an accountant for a medium-sized firm and has spent all her spare time for the past two years caring for her mother, who died two years after being incapacitated by a stroke. She has two married daughters who live across the country. She wants to control her hypertension so she doesn't end up like her mother and as a burden to her children.

Introduction

Hypertension has been termed the “silent killer.” Working with women to control their hypertension can positively affect their future health. Treating and controlling hypertension can decrease the risks of heart disease, death, myocardial infarction (MI), kidney disease, and stroke. Yet, fewer than half of individuals with hypertension receive treatment, and of those who are under treatment fewer than half are controlled well. Strokes may be prevented primarily or secondarily in individuals with certain risk factors, but the treatment is not completely effective.

Hypertension

Impact

Approximately one-fifth of adults over the age of 40 have high blood pressure. Hypertension is the most common cause of stroke in the UK and the most common cause of renal failure in the USA. Women are more likely than men to have hypertension, and the risk of hypertension increases with age.

Uncontrolled hypertension affects health profoundly negatively, and improving hypertension improves health.

Keywords

alcohol abuse concomitant diseases Cushing's syndrome diabetes parenchymal disease lifestyle changes pheochromocytoma hypertension primary aldosteronism stroke

Type: Chapter
Information: Women's Health in Mid-Life
A Primary Care Guide
, pp. 225 - 234

DOI: https://doi.org/10.1017/CBO9780511545672.013 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2004

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Brown, M. J.Science, medicine and the future. Hypertension. Br. Med. J. 1997; 314:1258CrossRef Google Scholar PubMed

O'Rorke, J. E. and Richardson, W. S.Evidence based management of hypertension: what to do when blood pressure is difficult to control. Br. Med. J. Br. Med. J.; 322:1229–32CrossRef Google Scholar

Mercuro, G., Sonco, S., Pilia, I., et al.Effects of acute administration of transdermal estrogen on postmenopausal women with systemic hypertension. Am. J. Cardiol. 1997; 80:652–7CrossRef Google Scholar PubMed

Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. NIH publication no. 98-4080. Bethesda, MD: National Institutes of Health; 1997

Little, P., Barnett, J., Barnsley, L., et al.Comparison of agreement between different measures of blood pressure in primary care and daytime ambulatory blood pressure. Br. Med. J. 200; 325:254–7CrossRef

Gueyffier, F., Boutitie, F., Boissel, J. P., et al.Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. Ann. Intern. Med.Ann. Intern. Med.; 126:761–7CrossRef

Huang, Z., Willett, W. C., Mason, J. E., et al.Body weight, weight change and the risk for hypertension in women. Ann. Intern. Med.Ann. Intern. Med.; 128:81–8CrossRef

Geleijnse, J. M., Wetteman, J. C., Back, A. A., Breijen, J. H. and Grobee, D. E.Reduction in blood pressure with a low sodium, high potassium, high magnesium salt in older subjects with mild to moderate hypertension. Br. Med. J. Br. Med. J.; 309:436–40CrossRef Google Scholar

Ramsay, L., Williams, B., Johnston, G., et al.Guidelines for management of hypertension: report of the third working party of the British Hypertension Society. J. Hum. Hypertens. 1999; 13:569–92CrossRef Google Scholar PubMed

Williams, B.Drug treatment of hypertension. Br. Med. J. USA 2003; 322:127–9Google Scholar

Mulrow, C. D. and Pignone, M.Evidence based management of hypertension: what are the elements of good treatment for hypertension?Br. Med. J. 2001; 322:1107–9CrossRef Google Scholar

Bosch, J., Yusuf, S., Pogue, J., et al.Use of ramipril in preventing stroke: double blind randomised trial. Br. Med. J. 2002; 324:699–702CrossRef Google Scholar PubMed

Mogensen, C. E., Neldam, S., Tikkanen, I., et al.Randomised controlled trial of dual blockade of renin–angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study. Br. Med. J. 2000; 321:1440–44CrossRef Google Scholar PubMed

Hansson, L., Lindholm, L. H., Ekbom, T., et al.Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity. The Swedish Trial in Old Patients with Hypertension-2 study. Lancet 1999; 354:1751–6CrossRef Google Scholar PubMed

Collaboration Blood Pressure Lowering Treatment Trialists. Effects of angiotensin converting enzyme inhibitors, calcium antagonists and other blood pressure lowering drugs on mortality and major cardiovascular morbidity. Lancet 2000; 356:1955–64

The ALLHAT Officers and Co-ordinators for the ALLHAT Collaborative Research Group. Major cardiovascular events in hypertensive patients randomly assigned to doxazosin vs chlorthalidone: the antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT). J. Am. Med. Assoc. 2002; 283:1967–75

Williams, B.Drug treatment of hypertension. Br. Med. J. 2003; 326:61–2CrossRef Google Scholar PubMed

Pope, J. E., Anderson, J. J. and Felson, D. T.A metaanalysis of the effects of non-steroidal anti-inflammatory drugs on blood pressure. Arch Intern. Med. 1992; 153:477–84CrossRef Google Scholar

Johnson, A. G., Nguyen, T. V. and Day, R. O.Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann. Intern. Med. 1994; 121:289–90CrossRef Google Scholar PubMed

Gubitz, G. and Sandercock, P.Prevention of ischaemic stroke. Br. Med. J. 2000; 321:1455–9CrossRef Google Scholar PubMed

Alberts, M. tPA in acute ischemic stroke. United States experience and issues for the future. Neurology 1988; 51 (supp 3):53–5SCrossRef Google Scholar

Lees, K. R., Bath, P. M. W. and Naylor, A. R.ABC of arterial and venous disease: secondary prevention of transient ischaemic attack and stroke. Br. Med. J. 2000; 320:991–4CrossRef Google Scholar PubMed

Gorelick, P. B., Sacco, R. L., Smith, D. B.et al.Prevention of a first stroke. A review of guidelines and a multidisciplinary consensus statement from the National Stroke Association. J. Am. Med. Assoc. 1999; 281:1112–20CrossRef Google Scholar

Hart, R. G., Benavente, O., McBride, R. and Pearce, L. A.Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann. Intern. Med. 1999; 131:492–501CrossRef Google Scholar PubMed

PROGRESS Management Committee. Blood pressure lowering for the secondary prevention of stroke: rationale and design of PROGRESS. J. Hypertens. 1996; 14 (supp 2):41–6SCrossRef

Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br. Med. J. 1994; 308:81–106CrossRef

The Stroke Prevention in Reversible Ischaemia Trial (SPIRIT) Study Group. A randomised trial of anticoagulant versus aspirin after cerebral ischemia of presumed arterial origin. Ann. Neurol. 1997; 42:857–65CrossRef

Hart, R. G., Benavente, O., McBride, R. and Pearce, L. A.Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta analysis. Ann. Intern. Med. 1999; 131:492–501CrossRef Google Scholar PubMed

Cina, C., Clase, C. and Haynes, R. Carotid endarterectomy for symptomatic stenosis. In: Cochrane Library, Issue 3. Oxford: Update Software; 1999

Book contents

13 - Hypertension and stroke

Summary

Keywords

Access options

References

Save book to Kindle

Save book to Dropbox

Save book to Google Drive